Escalating dosing regimen for effecting weight loss and treating obesity
US9011906B2 · kind B2 · utility
0Cited by
39References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 2014 |
| Grant date | Apr 21, 2015 |
| Priority date | — |
| Expiry date | Sep 24, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is drawn to novel topiramate compositions as well as methods for effecting weight loss, e.g., in the treatment of obesity and related conditions, including conditions associated with and/or caused by obesity per se. The present invention features an escalating dosing regimen adapted for the administration of topiramate and optionally a sympathomimetic agent such as phentermine or bupropion, in the treatment of obesity and related conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.